Approach to genetic diagnosis of inborn errors of immunity through next-generation sequencing.

Inborn errors of immunity Next-generation sequencing Primary immunodeficiency Whole-exome sequencing Whole-genome sequencing

Journal

Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289

Informations de publication

Date de publication:
09 2021
Historique:
received: 03 05 2021
revised: 18 06 2021
accepted: 23 06 2021
pubmed: 4 7 2021
medline: 29 9 2021
entrez: 3 7 2021
Statut: ppublish

Résumé

Patients with inborn errors of immunity (IEI) present with a heterogeneous clinical and immunological phenotype, therefore a correct molecular diagnosis is crucial for the classification and subsequent therapeutic management. On the other hand, IEI are a group of rare congenital diseases with highly diverse features and, in most cases, an as yet unknown genetic etiology. Next generation sequencing has facilitated genetic examinations of rare inherited disorders during the recent years, thus allowing a suitable molecular diagnosis in the IEI patients. This review aimed to investigate the current findings about these techniques in the field of IEI, suggesting an efficient stepwise approach to molecular diagnosis of inborn errors of immunity.

Identifiants

pubmed: 34216999
pii: S0161-5890(21)00193-0
doi: 10.1016/j.molimm.2021.06.018
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-66

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Esmat Karimi (E)

Department of Cellular and Molecular Medicine, College of Medicine, University of Arizona, Tucson, AZ, 85721, USA; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran.

Fatemeh Mahmoudian (F)

Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Saul O Lugo Reyes (SOL)

Immune Deficiencies Lab, National Institute of Pediatrics, Mexico City, Mexico.

Umair Ahmed Bargir (UA)

Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Manisha Madkaikar (M)

Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Hasibe Artac (H)

Department of Pediatric Immunology and Allergy, Faculty of Medicine, Selcuk University, Konya, Turkey.

Araz Sabzevari (A)

CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran.

Na Lu (N)

State Key Lab of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.

Gholamreza Azizi (G)

Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: azizi@abzums.ac.ir.

Hassan Abolhassani (H)

Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address: hassan.abolhassani@ki.se.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH